However, further analyses are necessary to determine whether astrocytic IKK2/NF-κB activation triggers a similar gene expression program recently found in so-called disease-associated-astrocytes (DAA) in AD, which appeared at early disease stages and increased in abundance with disease progression [70]. This evidence concerns the gene NFKB1 and Alzheimer disease.